definiens: shall mean a research, development and/or commercialization project that involves the use of any [COMPANY] Mice, and/or an exercise or grant of rights under any [COMPANY] Techn ology ( and, in [COMPANY] 's discretion, the additional use of any [COMPANY] Mice an d / or KM - Mice, and/or an exercise or grant of rights under any [COMPANY] Technol ogy and/or KM Patent Rights, in each case only under the [COMPANY] Evaluation Lice nse or a sublicense under the [COMPANY] Evaluation License in connection with the s ame project ), to Exploit and/or have Exploited Antibodies originally obtaine d, isolated, identified or derived from such mice ( and/or Antibody Materials r elated thereto and/or Antibody Products containing such Antibodies ) and w hich project is conducted by [COMPANY], a [COMPANY] Affiliate, and/or any Third Part y with which [COMPANY] has entered into a written agreement with respect to su ch project ; provided, however, that no project that involves the Exploita tion of Antibodies ( and/or Antibody Materials related thereto and/or Antibody Products containing such Antibodies ) raised against and with affinity for an Antigen with respect to which [COMPANY], in connection with such project, has exercised rights under a Reservation License or a Commercial License ( and/or for which [COMPANY], in connection with such project, has granted to a Thir d Party a sublicense under a Reservation License or a Commercial [ * ]= Certain confidential information contained in t his document, marked by brackets, has been omitted and filed separately wit h the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended